Anti-GRK2 antibody [EPR22465]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(4 Publications)
Rabbit Recombinant Monoclonal GRK2 antibody. Suitable for IP, WB and reacts with Human samples. Cited in 4 publications.
View Alternative Names
ADRBK1, BARK, BARK1, GRK2, Beta-adrenergic receptor kinase 1, Beta-ARK-1, G-protein coupled receptor kinase 2
- IP
Supplier Data
Immunoprecipitation - Anti-GRK2 antibody [EPR22465] (AB227825)
GRK2 was immunoprecipitated from 0.35 mg HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate with ab227825 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab227825 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1000 dilution.
Lane 1 : HEK-293T whole cell lysate 10 μg (Input).
Lane 2 : ab227825 IP in HEK-293T whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab227825 in HEK-293T whole cell lysate.
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : 3 seconds.
GRK2 was found readily degradable by proteolytic process (PMID : 9857063; PMID : 12738776). The bands smaller than 80-kDa detected in the immune-precipitate may represent degraded GRK2.
All lanes:
Immunoprecipitation - Anti-GRK2 antibody [EPR22465] (ab227825)
Predicted band size: 80 kDa
false
- IP
Supplier Data
Immunoprecipitation - Anti-GRK2 antibody [EPR22465] (AB227825)
GRK2 was immunoprecipitated from 0.35 mg HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate with ab227825 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab227825 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1000 dilution.
Lane 1 : HeLa whole cell lysate 10 μg (Input).
Lane 2 : ab227825 IP in HeLa whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab227825 in HeLa whole cell lysate.
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : 3 seconds.
GRK2 was found readily degradable by proteolytic process (PMID : 9857063; PMID : 12738776). The bands smaller than 80-kDa detected in the immune-precipitate may represent degraded GRK2.
All lanes:
Immunoprecipitation - Anti-GRK2 antibody [EPR22465] (ab227825)
Predicted band size: 80 kDa
false
- WB
Lab
Western blot - Anti-GRK2 antibody [EPR22465] (AB227825)
Lanes 1-4 : Merged signal (red and green). Green - ab227825 observed at 80 kDa. Red - loading control ab8245 observed at 36 kDa.
ab227825 Anti-GRK2 antibody [EPR22465] was shown to specifically react with GRK2 in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab266352 (knockout cell lysate ab257345) was used. Wild-type and GRK2 knockout samples were subjected to SDS-PAGE. ab227825 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-GRK2 antibody [EPR22465] (ab227825) at 1/1000 dilution
Lane 1:
Wild-type HEK293T cell lysate at 20 µg
Lane 2:
ADRBK1 knockout HEK293T cell lysate at 20 µg
Lane 2:
Western blot - Human ADRBK1 (GRK2) knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-adrbk1-grk2-knockout-hek-293t-cell-line-ab266352'>ab266352</a>)
Lane 3:
HepG2 cell lysate at 20 µg
Lane 4:
HeLa cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Predicted band size: 80 kDa
Observed band size: 80 kDa
false
- WB
Supplier Data
Western blot - Anti-GRK2 antibody [EPR22465] (AB227825)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-GRK2 antibody [EPR22465] (ab227825) at 1/1000 dilution
All lanes:
Human skeletal muscle lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/1000 dilution
Predicted band size: 80 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-GRK2 antibody [EPR22465] (AB227825)
Blocking/Dilution buffer : NFDM/TBST.
ab227825 was shown to specifically react with GRK2 in wild-type HAP1 cells as signal was lost in GRK2 knockout cells. Wild-type and GRK2 knockout samples were subjected to SDS-PAGE. ab227825 and ab181602 (Rabbit anti-GAPDH loading control) were incubated 1 hour at room temperature at 1/1000 dilution and 1/200,000 dilution respectively. Blots were developed with Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) secondary antibody at 1/100,000 dilution for 1 hour at room temperature before imaging. The blot was developed on a BIO-RAD® ChemiDoc™ MP instrument using the ECL technique.
All lanes:
Western blot - Anti-GRK2 antibody [EPR22465] (ab227825) at 1/1000 dilution
Lane 1:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 2:
GRK2 knockout HAP1 whole cell lysate at 20 µg
Lane 3:
HEK-293 (human epithelial cell line from embryonic kidney) whole cell lysate at 20 µg
Lane 4:
HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 5:
HepG2 (human liver hepatocellular carcinoma cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 80 kDa
false
Related conjugates and formulations (1)
-
Anti-GRK2 antibody [EPR22465] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
GRK2 acts by coordinating with other proteins to regulate signal transduction pathways. It usually forms a complex with arrestins which prevent further signaling by blocking G protein coupling and directing receptors towards internalization pathways. This kinase acts to modulate receptor activity and maintain cellular homeostasis. GRK2 is essential for preventing overstimulation of cells playing a role in neurobiology and cardiology.
Pathways
GRK2 plays an important role in the adrenergic receptor signaling pathways including the beta-adrenergic and alpha-adrenergic pathways. It participates in the regulation of cardiac output and vascular tone by influencing the response of cells to catecholamines like adrenaline and noradrenaline. Proteins related to GRK2 in these pathways include adrenergic receptor subtypes and arrestin proteins. Voltage-gated calcium channels also interact with GRK2 linking it to calcium signaling pathways vital for muscle contraction and neurotransmitter release.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Chemical science 15:2833-2847 PubMed38404368
2024
Applications
Unspecified application
Species
Unspecified reactive species
Aging 15:10524-10539 PubMed37815883
2023
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 25:276 PubMed37206562
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell death discovery 8:15 PubMed35013140
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com